Seattle Genetics, Inc. (SGEN) stock prices updated...
 

Seattle Genetics, Inc. stock price

Seattle Genetics, Inc. latest news:


  • 11/09/2017 10:52:26

    BRIEF-SEATTLE GENETICS ANNOUNCES FDA APPROVAL OF ADCETRIS (BRENTUXIMAB VEDOTIN)

    Seattle Genetics Inc(SGEN): * SEATTLE GENETICS ANNOUNCES FDA APPROVAL OF ADCETRIS® FOR PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA AND CD30-EXPRESSING MYCOSIS FUNGOIDES.

  • More trends:

    Second Sight Medical Products, Inc.EYES | Security National Financial CorporationSNFCA | SEI Investments CompanySEIC | Select Bancorp, Inc.SLCT | Select Comfort CorporationSCSS | Selectica, Inc.SLTC | Selective Insurance Group, Inc.SIGI | SemiLEDS CorporationLEDS | Semler Scientific, Inc.SMLR | Semtech CorporationSMTC |